Previous Page  241 / 320 Next Page
Information
Show Menu
Previous Page 241 / 320 Next Page
Page Background

645

21. Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective

randomised multi-centre controlled trial on tight glucose

control by intensive insulin therapy in adult intensive care units:

the Glucontrol study. Intensive Care Med. 2009;35(10):1738-

48.

22. Finfer S, Chittock D, Li Y, et al. Intensive versus Conventional

Glucose Control in Critically Ill Patients. The NICE-SUGAR Study

Investigators. N Engl J Med 2009; 360:1283-1297.

23. Kohn L. The Institute of Medicine report on medical error:

Overview and implications for pharmacy. Am J Health Syst

Pharm 2001;58: 63-6.

24. Leape L, Bates D, Cullen D, et al. Systems Analysis of Adverse

Drug Events. JAMA 1995;274: 35-43.

25. Seynaeve S, Verbrugghe W, Claes B, Vandenplas D, Reyntiens D,

Jorens PG. Adverse drug events in intensive care units: a cross-

sectional study of prevalence and risk factors. Am J Crit Care.

2011;20(6):131-40.

[CONSIDERACIONES FARMACOLÓGICAS GENERALES Y PARTICULARES EN CUIDADOS INTENSIVOS - Dr. Tomás Regueira, PhD]